LAVA Therapeutics NV Accounts Payable

LAVA Therapeutics NV (LVTX) currently reports a accounts payable of $1.7M as of September 2025. That compares with $2.8M in the prior-year period — down 39.7% year over year. Use the charts on this page to explore LAVA Therapeutics NV's accounts payable history and peer comparisons.

LAVA Therapeutics NV's accounts payable decreased from $2.8M to $1.7M — a 39.7% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LAVA Therapeutics NV reported $1.7M in accounts payable as of September 2025. That compares with $2.8M in the prior-year period — down 39.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $1.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LAVA Therapeutics NV, and consider following LVTX for alerts when major investors trade the stock.

LAVA Therapeutics NV is classified in the Healthcare sector. On accounts payable, it currently shows $1.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LVTX with unrelated industries.